NAVAMECH: Electrical Activity of the Diaphragm and Respiratory Mechanics During NAVA

Sponsor
University of Padova (Other)
Overall Status
Recruiting
CT.gov ID
NCT05689476
Collaborator
(none)
50
1
1
24
2.1

Study Details

Study Description

Brief Summary

Protective ventilatory strategy should be applied to reduce both ventilator-induced lung injury (VILI) and ventilator-induced diaphragm dysfunction (VIDD) after Lung Transplantation (LTx). Neurally Adjusted Ventilatory Assist (NAVA) is an assisted ventilation mode in which respiratory support is coordinated by the electrical activity of the diaphragm (EAdi). Aim of the study is to assess the physiological relationship between neural respiratory drive as assessed by EAdi and tidal volume, driving pressure and mechanical power, at different levels of ventilatory assist, in the absence of pulmonary vagal afferent feedback.

Condition or Disease Intervention/Treatment Phase
  • Device: NAVA GROUP
N/A

Detailed Description

Lung transplantation (LTx) is an important treatment option for select patients with end-stage pulmonary disease. In the early period following LTx a protective ventilatory strategy should be applied to reduce both ventilator-induced lung injury (VILI) and ventilator-induced diaphragm dysfunction (VIDD) after Lung Tranplantation (LTx). Neurally Adjusted Ventilatory Assist (NAVA) is an assisted ventilation mode in which neural inspiratory activity is monitored through the continuous recording of electrical activity of the diaphragm (EAdi) and then used to coordinate the respiratory support delivered by the ventilator.

NAVA, because of its intrinsic properties (proportionality between respiratory drive and level of assist, prevention of diaphragm atrophy), could allow the aforementioned ventilatory strategy, however it may require the integrity of the pulmonary vagal afferent feedback in order to avoid volutrauma. So, the aim of the study is the evaluation of the physiological relationship between EAdi and tidal volume, driving pressure and mechanical power, at different levels of ventilatory assist, in the absence of pulmonary vagal afferent feedback, in early post-operative period after LTx.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Masking Description:
none (open label)
Primary Purpose:
Treatment
Official Title:
Evaluation of the Relationship Between Electrical Activity of the Diaphragm and Respiratory Mechanics During Neurally Adjusted Ventilatory Assist in Lung Transplant Patients.
Actual Study Start Date :
Dec 27, 2022
Anticipated Primary Completion Date :
Dec 27, 2024
Anticipated Study Completion Date :
Dec 27, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: NAVA group

Nava ventilation

Device: NAVA GROUP
NAVA ventilation: Assisted Ventilation Mode, synchronized, through EAdi catheter, with patient's inspiratory effort and proportional to respiratory drive

Outcome Measures

Primary Outcome Measures

  1. Electrical Activity of the Diaphragm (EAdi) [One hour after the recovery of spontaneous breathing]

    Evaluation of the variations of tidal volume Electrical Activity of the Diaphragm in response to different levels of ventilatory assist at different degrees of lung inflation (different Positive End Expiratory Pressure values). Electrical Activity of the Diaphragm (EAdi) (microVolt)

  2. Neuro-Mechanical Coupling (NMC) [One hour after the recovery of spontaneous breathing]

    Evaluation of the variations of Neuro-Mechanical Coupling (expressed as microVolt of EAdi /cmH2O of airway pressure Ratio) in response to different levels of ventilatory assist at different degrees of lung inflation. Neuro-Mechanical Coupling (NMC) (microvolt/cmH2O)

  3. Neuro-Ventilatory Efficiency (NVE) [One hour after the recovery of spontaneous breathing]

    Evaluation of the variations of Neuro-ventilatory Efficiency (expressed as microvolt of EAdi / mL of Tidal Volume Ratio) in response to different levels of ventilatory assist at different degree of lung inflation. Neuro-Ventilatory Efficiency (NVE) (microvolt/mL)

  4. Respiratory rate (Breaths/min) [One hour after the recovery of spontaneous breathing]

    Evaluation of the changes in the patient's neural breathing pattern (expressed as mL of Tidal Volume) at different levels of ventilatory assist. Respiratory rate (Breaths/min)

Secondary Outcome Measures

  1. Plateau Pressure (Pplat) [One hour after the recovery of spontaneous breathing, with inspiratory hold manoeuvres]

    Evaluation of the feasibility of Plateau Pressure during NAVA.Plateau Pressure (Pplat)

  2. Diaphragm's Thickening Fraction (TF) [One hour after the recovery of spontaneous breathing]

    Ultrasound assessment of the changes of Diaphragm's Thickening Fraction at different levels of Positive End Expiratory Pressure and at different NAVA gains

  3. Total Asinchrony Index [One hour after the recovery of spontaneous breathing]

    Assesment of the total asynchrony index (double triggering + missed efforts + inspiratory trigger delay +short cycling + prolonged cycling)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age > 18 y.o.

  • Admission to ICU for post-operative monitoring after LTx

  • Presence of spontaneous breathing activity

  • Sedation titrated to a target RASS between 0 and -2

  • Written informed consent obtained

Exclusion Criteria:
  • Contraindication to nasogastric tube insertion (gastroesophageal surgery in the previous 3 months, gastroesophageal bleeding in the previous 30 days, history of esophageal varices, facial trauma)

  • Increased risk of bleeding with nasogastric tube insertion, due to severe coagulation disorders and severe thrombocytopenia ( i.e., INR > 2 and platelets count < 70.000/mm3)

  • Severe hemodynamic instability (noradenaline > 0.3 μg/kg/min and/or use of vasopressin)

  • Postoperative extracorporeal respiratory support (ECMO)

  • Pre-operative reconditioning of the transplanted lungs by means of ex-vivo lung perfusion (EVLP)

  • Lung retransplantation

  • Failure to obtain a stable EAdi signal

Contacts and Locations

Locations

Site City State Country Postal Code
1 Institute of Anaesthesia and Intensive Care, Padua University hospital Padova Italy 35120

Sponsors and Collaborators

  • University of Padova

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Padova
ClinicalTrials.gov Identifier:
NCT05689476
Other Study ID Numbers:
  • NAVAMECH
First Posted:
Jan 19, 2023
Last Update Posted:
Jan 26, 2023
Last Verified:
Dec 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Padova
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 26, 2023